Multiple sclerosis: manages to reduce the severity of symptoms with aspirin

Aspirin, used at low doses, may reduce the severity of Symptoms and abnormalities of the immune system patients with multiple sclerosis, according to a study published in the journal Science Signaling.

According to research, aspirin administered orally to laboratory mice "reduces the severity of symptoms, slows the degradation of myelin (the "white stuff") and inhibited the infiltration of cells into the spinal cord. "The amount of aspirin applied to the mice was the equivalent of a dose of the infant version of the drug.

Multiple sclerosis is a degenerative disease that affects more than 2.3 million people worldwide and is caused by loss of myelin, a protein of the nervous system responsible for the transmission of electrical impulses and the protection of neurons.

Researchers Rush University (Chicago) discovered an unknown effect of this common medication, commonly used to relieve pain.

With a small amount, aspirin was able to stimulate the production of positive cells for nerve transmission while slowing down the activity of these malignant cells (Treg) that "attack the nervous system, degrade the mile and are responsible for the imbalance that causes the symptoms of multiple sclerosis".

The scientific team, led by Susanta Mondal, emphasized the safety of the active ingredient of aspirin and its ease of administration, in order to reuse it "supportive therapy"For patients with multiple sclerosis and other autoimmune disorders badociated with dysfunction of the same Treg cells.